Insight2016-08-01T14:51:33-04:00
3103, 2023

Laidlaw acts as Co-Manager on the $287,500,000 Follow-On Offering for Viking Therapeutics.

By |March 31st, 2023|News|

Laidlaw is pleased to act as Co-Manager on Vikings 287.5mm dollar offering. Laidlaw Capital Markets was the Sole Book Runner on Viking’s 27.6mm dollar IPO in 2015. VKTX is now over a one Read More...

Laidlaw Capital Markets acts as Co-Lead Bookrunner on Cingulate Inc’s (CING) $25,000,000 Offering.

December 10th, 2021|Comments Off on Laidlaw Capital Markets acts as Co-Lead Bookrunner on Cingulate Inc’s (CING) $25,000,000 Offering.

Laidlaw Capital Markets is pleased to have been Co-Lead Bookrunner on Cingulate Inc's (CING) $25,000,000 Offering. Cingulate utilizes its proprietary Precision Timed Release (PTR) drug delivery platform technology to build and advance a pipeline of next-generation Read More...

Laidlaw Capital Markets is Financial Advisor on MEI Pharma Inc’s $52,325,000 Follow-On Offering

December 10th, 2021|Comments Off on Laidlaw Capital Markets is Financial Advisor on MEI Pharma Inc’s $52,325,000 Follow-On Offering

Laidlaw Capital Markets is pleased to be Financial Advisor on the MEI Pharma Inc’s $52,325,000 Follow-On Offering alongside Jefferies, Stifel, and Wells Fargo.” Link: https://www.meipharma.com/press-releases/mei-pharma-announces-closing-public-offering-common-stock-0

Ready to talk?

Lorem ipsum dolor sit amet, consectetur adipisicing elit mod tempor incididunt ut labore et dolore magna aliqua.

Site Info

Home
Contact Us
Company History

Legal

Terms and Conditions
Legal Information
Privacy Policy
Glossary
Record of Processing Activities
GDPR Rights Exercise Form

Disclosures

FINRA
SIPC
FCA
Business Continuity Plan Disclosure
Brokercheck
REGBI
StoneX Annual Disclosure
Options Disclosure Booklet

Contact Info

© 2024 Copyright Laidlaw & Company (UK) Ltd. – All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through StoneX, a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).

© Copyright 2016 Laidlaw & Company (UK) Ltd. - All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through INTL FCStone Financial Inc., a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).

You are now leaving Laidlaw & Company (UK) Ltd.

This link to the Private Stakes Program is provided as a service to Members, Clients and interested parties and will direct you to a third-party site independent of Laidlaw & Company (UK) Ltd.

Neither Laidlaw & Company (UK) Ltd. nor Laidlaw Private Equity, LLC own or manage the Private Stakes Program alternative investment vehicles. They are not responsible for the content of the site and do not guarantee the accuracy or completeness of any information or material contained therein.

Associated persons of Laidlaw & Company (UK) Ltd. and Laidlaw Private Equity, LLC are involved in the management and administration of each alternative investment vehicle described in the Private Stakes Program website.

Go to Top